M Gorczyca

726 total citations
33 papers, 565 citations indexed

About

M Gorczyca is a scholar working on Organic Chemistry, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, M Gorczyca has authored 33 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 12 papers in Genetics and 11 papers in Pathology and Forensic Medicine. Recurrent topics in M Gorczyca's work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (11 papers) and Synthesis and Reactions of Organic Compounds (6 papers). M Gorczyca is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (11 papers) and Synthesis and Reactions of Organic Compounds (6 papers). M Gorczyca collaborates with scholars based in United States, Poland and United Kingdom. M Gorczyca's co-authors include Axel Hoos, Zangdong He, Adam D. Cohen, Paul G. Richardson, Ira Gupta, Brandi Reeves, Heather J. Sutherland, Rakesh Popat, Larry D. Anderson and Suzanne Trudel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

M Gorczyca

31 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Gorczyca United States 11 230 217 201 199 173 33 565
Michael Gulrajani United States 8 542 2.4× 408 1.9× 111 0.6× 206 1.0× 162 0.9× 18 662
James Berenson United States 11 100 0.4× 97 0.4× 250 1.2× 207 1.0× 310 1.8× 23 564
James Huang United States 11 228 1.0× 371 1.7× 232 1.2× 63 0.3× 131 0.8× 32 547
Dennis Demont Netherlands 6 280 1.2× 206 0.9× 67 0.3× 109 0.5× 187 1.1× 8 490
Fanny Krantz United States 7 401 1.7× 300 1.4× 92 0.5× 147 0.7× 129 0.7× 12 495
Beth Fischer United States 9 426 1.9× 309 1.4× 328 1.6× 158 0.8× 298 1.7× 28 829
Rosalind H. Gunby Italy 13 222 1.0× 85 0.4× 180 0.9× 267 1.3× 316 1.8× 17 683
Josephine L. Klitgaard United States 7 171 0.7× 97 0.4× 133 0.7× 108 0.5× 178 1.0× 11 426
Lesley Liu‐Bujalski United States 7 192 0.8× 104 0.5× 62 0.3× 70 0.4× 146 0.8× 10 346
Elisabeth A. Lasater United States 12 222 1.0× 59 0.3× 146 0.7× 559 2.8× 522 3.0× 21 963

Countries citing papers authored by M Gorczyca

Since Specialization
Citations

This map shows the geographic impact of M Gorczyca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Gorczyca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Gorczyca more than expected).

Fields of papers citing papers by M Gorczyca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Gorczyca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Gorczyca. The network helps show where M Gorczyca may publish in the future.

Co-authorship network of co-authors of M Gorczyca

This figure shows the co-authorship network connecting the top 25 collaborators of M Gorczyca. A scholar is included among the top collaborators of M Gorczyca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Gorczyca. M Gorczyca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarker, Debashis, Nancy A. Dawson, Ana M. Aparicio, et al.. (2021). A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 27(19). 5248–5257. 22 indexed citations
2.
Trudel, Suzanne, Nikoletta Lendvai, Rakesh Popat, et al.. (2018). Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial. The Lancet Oncology. 19(12). 1641–1653. 192 indexed citations
3.
Österborg, Anders, Andrey Zaritskey, Sebastian Grosicki, et al.. (2016). Phase III, randomized study of ofatumumab versus physicians’ choice of therapy and standard versus extended-length ofatumumab in patients with bulky fludarabine-refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 57(9). 2037–2046. 20 indexed citations
4.
Jewell, Roxanne C., Thomas J. Kipps, Jan Dürig, et al.. (2016). Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy. Leukemia & lymphoma. 58(2). 348–356. 3 indexed citations
5.
Robak, Tadeusz, Krzysztof Warzocha, Govind Babu, et al.. (2016). Ofatumumab plus fludarabine and cyclophosphamide in relapsed chronic lymphocytic leukemia: results from the COMPLEMENT 2 trial. Leukemia & lymphoma. 58(5). 1084–1093. 39 indexed citations
6.
Robak, Tadeusz, Sebastian Grosicki, Krzysztof Warzocha, et al.. (2015). Ofatumumab (O) in combination with fludarabine (F) and cyclophosphamide (C) (OFC) vs. FC in patients with relapsed chronic lymphocytic leukaemia (CLL): results of the phase III study complement 2. Haematologica. 100. 3 indexed citations
7.
Wierda, William G., Thomas J. Kipps, Jan Dürig, et al.. (2011). Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia. Blood. 117(24). 6450–6458. 86 indexed citations
8.
Wierda, William G., Thomas J. Kipps, Laimonas Griškevičius, et al.. (2010). Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 28(15_suppl). 6520–6520. 1 indexed citations
9.
10.
Pinto, Ivan L., Richard L. Jarvest, Brian Clarke, et al.. (1999). Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism. Bioorganic & Medicinal Chemistry Letters. 9(3). 449–452. 28 indexed citations
11.
Drabczyńska, Anna, et al.. (1996). The influence of new 9-(omega-[4-(2-pyrimidinyl)-1-piperazinyl]alkyl) pyrimidino[2,1-f]purines on the central nervous system.. PubMed. 47(2). 169–73.
12.
Pawłowski, Maciej, et al.. (1995). Tricyclic theophylline derivatives with high water-solubility: structure-activity relationships at adenosine receptors, phosphodiesterases, and benzodiazepine binding sites.. PubMed. 50(5). 333–6. 6 indexed citations
13.
Pawłowski, Maciej, et al.. (1994). Synthesis and pharmacological screening of novel 10-substituted diazepino-[2,1-f]-purines.. PubMed. 51(4-5). 385–91. 6 indexed citations
14.
Pawłowski, Maciej, et al.. (1992). Synthesis and preliminary pharmacological assessment of novel 9-alkylamino substituted pyrimidino-[2,1-f]-purines.. PubMed. 43(1). 487–503. 4 indexed citations
15.
Malawska, Barbara, et al.. (1990). Synthesis and crystal and molecular structure of newN-substituted ?-hydroxybutyramides. Journal of Chemical Crystallography. 20(2). 139–144. 1 indexed citations
16.
Pawłowski, Maciej & M Gorczyca. (1982). ChemInform Abstract: N‐DEBENZYLATION REACTION OF 8‐(BENZYLAMINO)XANTHINES. PART I. SYNTHESIS OF 8‐AMINOTHEOPHYLLINE AND SOME OF ITS DERIVATIVES. Chemischer Informationsdienst. 13(34). 1 indexed citations
17.
Gorczyca, M, et al.. (1981). Synthesis and properties of 7-hydroxyalkyl- and 7-hydroxyalkylamino-8-benzylaminotheophylline derivatives.. PubMed. 32(5). 779–88. 2 indexed citations
18.
Gorczyca, M, et al.. (1977). Synthesis of 3-aminoalkyl derivatives of 5-5-diphenylhydantoin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25(2). 291–5. 1 indexed citations
19.
Rj, Gryglewski, et al.. (1976). Design of a new prostaglandin synthetase inhibitors in a group of N-(2-carboxyphenyl)phenoxyacetamides and their antiinflammatory activity.. PubMed. 1. 117–20. 2 indexed citations
20.
Gorczyca, M, et al.. (1975). Synthesis and properties of 7-hydroxyalkyl-8-benzylaminotheophyllines.. PubMed. 27(3). 305–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Gulrajani Breakdown of academic impact, for papers by James Berenson Breakdown of academic impact, for papers by James Huang Breakdown of academic impact, for papers by Dennis Demont Breakdown of academic impact, for papers by Fanny Krantz Breakdown of academic impact, for papers by Beth Fischer Breakdown of academic impact, for papers by Rosalind H. Gunby Breakdown of academic impact, for papers by Josephine L. Klitgaard Breakdown of academic impact, for papers by Lesley Liu‐Bujalski Breakdown of academic impact, for papers by Elisabeth A. Lasater
Rankless by CCL
2026